Cerebrospinal fluid matrix metalloproteinase-9 increases during treatment of recurrent malignant gliomas

Cerebrospinal Fluid Research

Volumn 5, Issue , 2008, Pages

  Wong, Eric T ^a   Alsop, David ^a   Lee, Diana ^a   Tam, Angela ^a   Barron, Loretta ^a   Bloom, Julianne ^a   Gautam, Shiva ^a   Wu, Julian K ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; GELATINASE B; IRINOTECAN; THALIDOMIDE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID EXAMINATION; COHORT ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG DOSE REGIMEN; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; LUMBAR PUNCTURE; LUNG EMBOLISM; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RECURRENT CANCER; TUMOR CELL LINE; TUMOR GROWTH; ZYMOGRAPHY;

EID: 40549134522     PISSN: 17438454     EISSN: None     Source Type: Journal    
DOI: 10.1186/1743-8454-5-1     Document Type: Article

References (29)